Cargando…

Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis

BACKGROUND: Recently, the use of immunochemotherapy in the treatment of advanced gastric cancer (GC) has been increasing and programmed cell death protein 1 (PD-1) inhibitors combined with chemotherapy has become the first-line treatment for advanced GC. However, few studies with small sample sizes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Hao, Li, Tengyun, Shao, Guoyi, Wang, Weizhi, He, Zhongyuan, Xu, Jianghao, Qian, Yawei, Liu, Hongda, Ge, Han, Wang, Linjun, Zhang, Diancai, Yang, Li, Li, Fengyuan, Xu, Zekuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326549/ https://www.ncbi.nlm.nih.gov/pubmed/37426646 http://dx.doi.org/10.3389/fimmu.2023.1193614

Ejemplares similares

Risk factors and conservative therapy outcomes of anastomotic leakage after gastrectomy: Experience of 3,926 patients from a single gastric surgical unit
por: He, Zhongyuan, et al.
Publicado: (2023)

Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2‐mediated autophagy
por: Fang, Lang, et al.
Publicado: (2022)

miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10
por: Li, Bowen, et al.
Publicado: (2017)

Retraction Notice to: miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10
por: Li, Bowen, et al.
Publicado: (2022)

Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2‐Robo1 signalling on cell migration and EMT
por: Xia, Yiwen, et al.
Publicado: (2019)

Muscarinic acetylcholine receptor 3 mediates vagus nerve-induced gastric cancer
por: Wang, Linjun, et al.
Publicado: (2018)

Laparoscopic distal gastrectomy demonstrates acceptable outcomes regarding complications compared to open surgery for gastric cancer patients with pylorus outlet obstruction
por: Wang, Sen, et al.
Publicado: (2023)

MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer
por: He, Zhongyuan, et al.
Publicado: (2018)

Multi‑institutional development and validation of a nomogram to predict prognosis of early-onset gastric cancer patients
por: Liu, Hongda, et al.
Publicado: (2022)

Netrin-1 promotes cell neural invasion in gastric cancer via its receptor neogenin
por: Yin, Kai, et al.
Publicado: (2019)

HIF-1α regulates cellular metabolism, and Imatinib resistance by targeting phosphogluconate dehydrogenase in gastrointestinal stromal tumors
por: Xu, Kangjing, et al.
Publicado: (2020)

Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition
por: Li, Qiang, et al.
Publicado: (2018)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer
por: Li, Qing, et al.
Publicado: (2017)

Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway
por: Yin, Kai, et al.
Publicado: (2017)

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer
por: Dai, Huiru, et al.
Publicado: (2022)

Safety of Neoadjuvant Immunotherapy in Resectable Cancers: A Meta-Analysis
por: Xu, Jiawei, et al.
Publicado: (2022)

Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Lv, Huilai, et al.
Publicado: (2022)

A high interferon gamma signature of CD8(+) T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer
por: Li, Sen, et al.
Publicado: (2023)

Efficacy and safety evaluation of neoadjuvant immunotherapy plus chemotherapy for resectable non–small cell lung cancer in real world
por: Fang, Min, et al.
Publicado: (2023)

Quantification of Tumor Abnormal Proteins in the Diagnosis and Postoperative Prognostic Evaluation of Gastric Cancer
por: Gu, Chao, et al.
Publicado: (2022)

CircFAM73A promotes the cancer stem cell-like properties of gastric cancer through the miR-490-3p/HMGA2 positive feedback loop and HNRNPK-mediated β-catenin stabilization
por: Xia, Yiwen, et al.
Publicado: (2021)

Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis
por: Zhang, Xing, et al.
Publicado: (2018)

Comparison of neoadjuvant nab‐paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
por: Yang, Yafan, et al.
Publicado: (2023)

Natriuretic peptide receptor a promotes gastric malignancy through angiogenesis process
por: Li, Zheng, et al.
Publicado: (2021)

Stratified treatment of localized cervical esophageal squamous cell carcinoma induced by neoadjuvant immunotherapy plus chemotherapy (SCENIC)
por: Li, Chunguang, et al.
Publicado: (2022)

Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway
por: Zhou, Jianping, et al.
Publicado: (2015)

Erratum to: Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway
por: Zhou, Jianping, et al.
Publicado: (2016)

MiR‐5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer
por: Miao, Yongchang, et al.
Publicado: (2020)

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2023)

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study
por: Zhao, Junfeng, et al.
Publicado: (2023)

CircTHBS1 drives gastric cancer progression by increasing INHBA mRNA expression and stability in a ceRNA- and RBP-dependent manner
por: Qiu, Shengkui, et al.
Publicado: (2022)

Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression
por: Sun, Guangli, et al.
Publicado: (2020)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Neoadjuvant immunotherapy for resectable esophageal cancer: A review
por: Li, Qing, et al.
Publicado: (2022)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Jiang, Ben‐Yuan, et al.
Publicado: (2021)

Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes
por: Xu, Ming, et al.
Publicado: (2014)

Neoadjuvant PD‐1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung
por: Feng, Yuan, et al.
Publicado: (2021)

Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis
por: Wang, He, et al.
Publicado: (2022)

Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis
por: Yu, Guocan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_putrvbnlu4cqb063mfh41mc2uv